Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norzyme vs Creon in Exocrine Pancreatic Insufficiency
NCT01228643Phase 3Withdrawn
- Sponsor
- Azidus Laboratories Limited
- Start
- Jun 2007
- Primary completion
- Nov 2011
- Countries
- 1
01
Overview
A Phase 3 trial of pancreatin in exocrine pancreatic insufficiency (EPI), sponsored by Azidus Laboratories Limited. Planned start Jun 2007; status: withdrawn.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT01228643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01228643.